The correlation of p22(phox) and chemosensitivity in EGFR-TKI resistant lung adenocarcinoma

BACKGROUND: Enhancing the chemosensitivity in the patients with epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) resistant lung adenocarcinoma (LUAD) is pivotal in achieving their successful therapeutic outcome. We aimed to explore the mechanisms regarding the development of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Kobayashi, Masayuki, Saito, Ryoko, Miki, Yasuhiro, Nanamiya, Ren, Inoue, Chihiro, Abe, Jiro, Sato, Ikuro, Okada, Yoshinori, Sasano, Hironobu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6383684/
https://www.ncbi.nlm.nih.gov/pubmed/30800222
http://dx.doi.org/10.18632/oncotarget.26637

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6383684/
https://www.ncbi.nlm.nih.gov/pubmed/30800222
http://dx.doi.org/10.18632/oncotarget.26637

Ejemplares similares